A statement released earlier today by RBC Capital Markets about Walgreen Boots Alliance (NDAQ:WBA) bumps down the target price to $94.00

Boasting a price of $78.74, Walgreen Boots Alliance (NDAQ:WBA) traded -1.68% lower on the day. With the last stock price close down -0.79% from the two hundred day average, compared with the S&P 500 Index which has increased 0.04% over the date range. Walgreen Boots Alliance has recorded a 50-day average of $81.36 and a two hundred day average of $81.86. Volume of trade was up over the average, with 7,442,764 shares of WBA changing hands over the typical 5,645,710

RBC Capital Markets bumped down the target of Walgreen Boots Alliance (NDAQ:WBA) to $94.00 stating a potential upside of 0.19%.

On 9/19/2017, RBC Capital Markets released a statement for Walgreen Boots Alliance (NDAQ:WBA) bumped up the target price from $0.00 to $96.00 that suggested an upside of 0.18%.

Performance Chart

With a total market value of $0, Walgreen Boots Alliance has price-earnings ratio of 20.51 with a one year low of $75.18 and a one year high of $89.69 .

A total of 22 equity analysts have released a research note on WBA. Six equity analysts rating the company a strong buy, ten equity analysts rating the company a buy, ten equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $93.59.

More About Walgreen Boots Alliance (NDAQ:WBA)

Walgreens Boots Alliance, Inc. is a holding company. The Company is a pharmacy-led health and wellbeing company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The Company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

7 − 1 =